Dr Kelly Loffler has a background in basic biomedical science and animal models of human disease, with previous experience in cancer research, including basic biology, genomics, management of tissue and tumour banks, and clinical trials.
At AISH, she has worked extensively with data from the international Sleep Apnea and cardioVascular Endpoints (SAVE) trial to build a more comprehensive picture of the relationship between obstructive sleep apnea and other aspects of cardiometabolic health. The surprising results from the SAVE trial triggered Dr Loffler's interest in identifying better ways of understanding and quantifying sleep and its relationship with general health.
Current responsibilities include clinical trial protocol development, data management and analysis in the area of sleep health, with a particular focus on the physiology of obstructive sleep apnea. Dr Loffler also works with other investigators in project management and implementation of both investigator-initiated and externally sponsored clinical research, and is involved in development and ongoing management of systems for managing clinical research operations.
Clinical trial design and implementation, protocol development, data management and analysis
You consent to the use of our cookies if you proceed.